Thomas Raffin MD

Thomas Raffin MD General Information

Biography

Dr. Thomas Raffin is a Co-Founder and serves as Senior Partner and Venture Partner at Telegraph Hill Partners. He serves as Board Member at ObservSMART. He also serves as Board Member at Perspective Therapeutics, Pandemonium Aviaries, and Lumos Pharma. He spent 30 years on the faculty at Stanford University School of Medicine where he remains the Colleen and Robert Haas Professor Emeritus of Medicine and Biomedical Ethics, former Chief of Pulmonary and Critical Care Medicine, and Co-Founder and Director Emeritus of the Stanford University Center for Biomedical Ethics. He has been an active clinician, teacher, and investigator, and has written over 200 articles, chapters, and books. Over the past two decades, he has worked extensively in the healthcare and medical device business sectors and was an advisor to Cell Therapeutics Inc. (1993-1997), Broncus Technologies (1997-2004), iMedica (1998-2002), and Inhale Technologies (1998-2001). He co-founded Rigel Pharmaceuticals in 1996. In 2001 he co-founded as a General Partner the San Francisco life sciences private equity firm Telegraph Hill Partners. He has been a member of the Board of Directors of AngioScore, Confirma, Freedom Innovations, LDR, and PneumRx. He served on the Board of Directors of the Humane Society Silicon Valley, TrakCel, and Aquaro Histology. He served as a Board Member at NewLink Genetics. He received a BA from Stanford University and an M.D. from Stanford University School of Medicine and a medical residency at the Peter Bent Brigham Hospital in Boston.